// App-Quantinova.ai

SU-OR21 : Variation in Peritoneal Dialysis-Related Peritonitis Outcomes and Treatment Practices: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study

Researchers

Presenter

  • Al sahlawi Muthana

Principal Investigators

  • McCullough Keith

  • Pisoni RonaldL

  • Fuller DouglasS

  • Zhao Junhui

  • Boudville Neil

  • Ito Yasuhiko

  • Kanjanabuch Talerngsak

  • Nessim Sharon

  • Piraino BethM

  • Teitelbaum Isaac

  • Johnson DavidW

  • Woodrow Graham

  • Perl Jeffrey

Medical Centers

  • Division of Nephrology St. Michael’s Hospital and the Keenan Research Center in the Li Ka Shing Knowledge Institute St. Michael’s Hospital University of Toronto Toronto Ontario Canada Toronto Ontario Canada

  • Arbor Research Collaborative for Health, Ann Arbor, United States of America

  • Medical School University of Western Australia Perth Australia Perth Western Australia Australia

  • Aichi Medical University Nagakute Japan Nagakute Japan

  • Center of Excellence in Kidney Metabolic Disorders and Division of Nephrology Department of Internal Medicine Chulalongkorn University Bangkok Thailand Bangkok Thailand

  • Division of Nephrology Jewish General Hospital McGill University Montreal Canada Montreal Quebec Canada

  • University of Pittsburgh Pittsburgh PA United States Pittsburgh Pennsylvania United States

  • University of Colorado Aurora CO United States Aurora Colorado United States

  • Department of Nephrology Princess Alexandra Hospital Brisbane Queensland Australia

  • Renal Unit St James’s University Hospital Leeds United Kingdom Leeds United Kingdom

  • Division of Nephrology St. Michael’s Hospital and the Keenan Research Center in the Li Ka Shing Knowledge Institute St. Michael’s Hospital University of Toronto Toronto Ontario Canada Toronto Ontario Canada

Locations

  • Canada

  • United States

  • Australia

  • Japan

  • Thailand

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Peritonitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A